WEBVTT 00:00:00.000 --> 00:00:02.140 OK, let's unpack this. Welcome to the Deep Dive. 00:00:02.299 --> 00:00:06.480 Our mission today is really laser focused on 00:00:06.480 --> 00:00:09.619 one of the most powerful yet intensely scrutinized 00:00:09.619 --> 00:00:12.220 entities in American health care, DaVita Inc. 00:00:12.400 --> 00:00:14.960 That's right. This company specializes in a single 00:00:14.960 --> 00:00:17.760 life or death service kidney dialysis and its 00:00:17.760 --> 00:00:20.989 business model. Well, it provides a perfect high 00:00:20.989 --> 00:00:23.789 stakes illustration of how health care, massive 00:00:23.789 --> 00:00:25.850 corporate finance and government subsidies all 00:00:25.850 --> 00:00:28.469 intersect. It's a deep dive into what is really 00:00:28.469 --> 00:00:30.969 critical infrastructure. I mean, we are analyzing 00:00:30.969 --> 00:00:34.109 a stack of sources here detailing DaVita's extraordinary 00:00:34.109 --> 00:00:37.409 scale, its unique financial dependence on a highly 00:00:37.409 --> 00:00:39.850 specific mix of government and commercial payers 00:00:39.850 --> 00:00:44.049 and a decades long trail of high stakes legal 00:00:44.049 --> 00:00:46.429 battles, settlements and regulatory scrutiny. 00:00:46.630 --> 00:00:49.210 And the stakes here are just. They're profound, 00:00:49.509 --> 00:00:51.490 they're personal, and they are non -negotiable. 00:00:51.570 --> 00:00:53.189 We're talking about end -stage renal disease 00:00:53.189 --> 00:00:56.409 or ESRD. Right. If you or someone you know faces 00:00:56.409 --> 00:00:59.030 this diagnosis, the treatment kidney dialysis 00:00:59.030 --> 00:01:01.630 is mandatory. It is not optional care you can 00:01:01.630 --> 00:01:04.170 postpone or shop around for leisurely. No, absolutely 00:01:04.170 --> 00:01:06.730 not. Patients require this life -sustaining intervention, 00:01:07.090 --> 00:01:09.650 usually three times a week, for the rest of their 00:01:09.650 --> 00:01:13.000 lives unless they receive a transplant. DaVita 00:01:13.000 --> 00:01:15.120 is one of the dominant forces delivering this 00:01:15.120 --> 00:01:17.560 care across the country. And that necessity, 00:01:17.799 --> 00:01:20.560 that absolute medical need, creates a unique 00:01:20.560 --> 00:01:23.180 market dynamic. I mean, when your survival literally 00:01:23.180 --> 00:01:26.319 depends on a service, the providers of that service 00:01:26.319 --> 00:01:28.760 hold incredible financial and political leverage. 00:01:29.079 --> 00:01:31.000 So our discussion today is essentially about 00:01:31.000 --> 00:01:34.219 how DaVita maximized that leverage within a system 00:01:34.219 --> 00:01:36.180 where the government is the primary insurer, 00:01:36.340 --> 00:01:39.140 but not the primary source of profit. That is 00:01:39.140 --> 00:01:41.980 the core contradiction. The first hook that captures... 00:01:42.000 --> 00:01:44.319 this tension perfectly, is the juxtaposition 00:01:44.319 --> 00:01:46.620 of their corporate standing against their legal 00:01:46.620 --> 00:01:49.379 woes. We are examining a company that hit, what, 00:01:49.400 --> 00:01:53.180 U .S. $12 .8 billion in revenue in 2024? An incredible 00:01:53.180 --> 00:01:55.840 number. And it's recognized as a component of 00:01:55.840 --> 00:01:58.340 the S &P 500, meaning it's one of the 500 largest, 00:01:58.500 --> 00:02:00.780 most robust public credit companies in the U 00:02:00.780 --> 00:02:03.180 .S. A blue chip company by any definition. And 00:02:03.180 --> 00:02:05.640 yet this blue chip giant is currently facing 00:02:05.640 --> 00:02:08.419 multiple federal investigations and a major class 00:02:08.419 --> 00:02:10.699 action lawsuit alleging market manipulation. 00:02:11.370 --> 00:02:13.610 That is the core contradiction we need to dissect 00:02:13.610 --> 00:02:15.490 for you. You have the stability and essential 00:02:15.490 --> 00:02:17.750 service delivery on one side, and then on the 00:02:17.750 --> 00:02:19.949 other, you have this pattern of aggressive financial 00:02:19.949 --> 00:02:22.969 maneuvering and, well, significant legal risk. 00:02:23.129 --> 00:02:25.069 To really understand the complexity, we have 00:02:25.069 --> 00:02:27.050 to start with the sheer physical and financial 00:02:27.050 --> 00:02:30.030 scale of DaVita. I mean, until you map out their 00:02:30.030 --> 00:02:32.650 footprint, it's almost impossible to appreciate 00:02:32.650 --> 00:02:35.949 how... fundamentally entwined they are with the 00:02:35.949 --> 00:02:38.169 U .S. health care system. Let's define that footprint 00:02:38.169 --> 00:02:41.770 first. The company is strategically incorporated 00:02:41.770 --> 00:02:44.129 in Delaware, which is very common for large U 00:02:44.129 --> 00:02:46.990 .S. corporations for legal and tax reasons. But 00:02:46.990 --> 00:02:49.469 their operational headquarters are in Denver, 00:02:49.590 --> 00:02:51.870 Colorado. OK, so that's the corporate structure. 00:02:52.069 --> 00:02:54.189 Now let's look at the U .S. market dominance, 00:02:54.509 --> 00:02:56.669 because our sources paint a very clear picture 00:02:56.669 --> 00:03:01.419 of concentration. DaVita operates 2 ,675 outpatient 00:03:01.419 --> 00:03:03.860 centers across the country. And that is a massive 00:03:03.860 --> 00:03:06.759 network. It is. And this extensive network serves 00:03:06.759 --> 00:03:11.240 200 ,000 to 1 ,800 patients. That 2 ,675 number 00:03:11.240 --> 00:03:14.800 is, frankly, staggering. And here's why you should 00:03:14.800 --> 00:03:17.300 care about that number. It indicates the accessibility 00:03:17.300 --> 00:03:20.439 of their services. Dialysis is administered three 00:03:20.439 --> 00:03:22.259 times a week. Right. You can't travel far for 00:03:22.259 --> 00:03:24.080 it. You can't. Patients must have a clinic near 00:03:24.080 --> 00:03:27.099 them. So by owning this many centers, DaVita 00:03:27.099 --> 00:03:30.039 is effectively a local monopoly or duopoly in 00:03:30.039 --> 00:03:32.139 thousands of communities across America. And 00:03:32.139 --> 00:03:33.780 what does that mean for the overall market when 00:03:33.780 --> 00:03:35.419 you have that kind of local concentration? It 00:03:35.419 --> 00:03:38.969 means that DaVita holds a significant 30... percent 00:03:38.969 --> 00:03:42.009 market share in the U .S. dialysis market. This 00:03:42.009 --> 00:03:44.330 is where the structural issue of the entire dialysis 00:03:44.330 --> 00:03:46.669 industry comes into sharp focus. So it's not 00:03:46.669 --> 00:03:49.969 just DaVita. No. With DaVita holding 37 percent 00:03:49.969 --> 00:03:52.229 and its main competitor, Fresenius Medical Care, 00:03:52.370 --> 00:03:55.569 holding a similar share, you have a highly consolidated 00:03:55.569 --> 00:03:58.409 duopoly dominating a non -elective life -sustaining 00:03:58.409 --> 00:04:00.870 service. Wow. So roughly three quarters of all 00:04:00.870 --> 00:04:03.069 U .S. dialysis patients are served by just two 00:04:03.069 --> 00:04:06.080 companies. Exactly. Two. When we talk about monopolies 00:04:06.080 --> 00:04:07.939 or duopolies in other sectors, you know, like 00:04:07.939 --> 00:04:11.139 tech or logistics, consumers can eventually switch 00:04:11.139 --> 00:04:13.759 or new services can be innovated. There's some 00:04:13.759 --> 00:04:15.819 kind of market pressure. Right. There's an escape 00:04:15.819 --> 00:04:19.199 valve. But in critical, mandatory medical care, 00:04:19.319 --> 00:04:22.759 that level of concentration. It significantly 00:04:22.759 --> 00:04:26.160 limits patient choice, which, as we'll see later, 00:04:26.279 --> 00:04:28.639 provides enormous leverage for these companies. 00:04:28.860 --> 00:04:32.139 Absolutely. And while the U .S. is their heartland, 00:04:32.259 --> 00:04:35.000 their core business, they aren't purely a domestic 00:04:35.000 --> 00:04:37.540 player. Their international reach, while it's 00:04:37.540 --> 00:04:40.240 smaller in terms of revenue contribution, is 00:04:40.240 --> 00:04:42.500 still pretty substantial. So what does that global 00:04:42.500 --> 00:04:45.649 presence look like? While DaVita operates 367 00:04:45.649 --> 00:04:48.329 outpatient centers and 11 other countries, serving 00:04:48.329 --> 00:04:52.189 an additional 49 ,400 patients globally. This 00:04:52.189 --> 00:04:54.410 international footprint demonstrates their operational 00:04:54.410 --> 00:04:56.589 reach and, you know, it allows the company to 00:04:56.589 --> 00:04:58.569 leverage efficiency and best practices across 00:04:58.569 --> 00:05:01.189 different regulatory environments. But the main 00:05:01.189 --> 00:05:04.290 event is the U .S. Oh, for sure. Their core regulatory 00:05:04.290 --> 00:05:06.649 and financial challenges remain rooted right 00:05:06.649 --> 00:05:08.889 here in the U .S. system. Let's pivot to the 00:05:08.889 --> 00:05:11.430 corporate identity then and the hard financial 00:05:11.430 --> 00:05:14.290 numbers from 2024. We already mentioned the US 00:05:14.290 --> 00:05:17.370 $12 .8 billion in revenue. That level of revenue 00:05:17.370 --> 00:05:19.730 dedicated to treating one single chronic condition 00:05:19.730 --> 00:05:23.819 is just... It is. And when you look at the profitability 00:05:23.819 --> 00:05:26.740 metrics, you see exactly why this company is 00:05:26.740 --> 00:05:30.019 considered an institutional powerhouse. The 2024 00:05:30.019 --> 00:05:33.439 financial snapshot, it reveals some serious operational 00:05:33.439 --> 00:05:36.259 efficiency. Their operating income stood at US 00:05:36.259 --> 00:05:40.920 $2 .09 billion and the net income was US $1 .25 00:05:40.920 --> 00:05:44.279 billion. And for listeners who may be curious 00:05:44.279 --> 00:05:45.779 about the difference there between operating 00:05:45.779 --> 00:05:48.100 income and net income, operating income tells 00:05:48.100 --> 00:05:50.100 you how much money the core business makes before 00:05:50.100 --> 00:05:55.459 tax. So how efficient they are at running those 00:05:55.459 --> 00:05:57.819 thousands of dialysis centers. Exactly. And net 00:05:57.819 --> 00:05:59.680 income is the bottom line. What's left for the 00:05:59.680 --> 00:06:01.779 shareholders after all expenses, taxes and interest 00:06:01.779 --> 00:06:04.420 are paid. The fact that they retain over a billion 00:06:04.420 --> 00:06:07.100 dollars in net income speaks to incredible discipline. 00:06:07.300 --> 00:06:09.740 And that operational discipline is absolutely 00:06:09.740 --> 00:06:13.860 necessary because structurally, DaVita is a capital 00:06:13.860 --> 00:06:17.240 intensive organization. Their total assets are 00:06:17.240 --> 00:06:22.660 valued at U .S. $17 .3 billion. 17 billion. That 00:06:22.660 --> 00:06:26.220 figure underscores the enormous fixed cost base 00:06:26.220 --> 00:06:29.110 required to run this whole operation. You have 00:06:29.110 --> 00:06:31.490 to own or lease thousands of clinics. You have 00:06:31.490 --> 00:06:33.790 to purchase and maintain millions of dollars 00:06:33.790 --> 00:06:36.110 worth of specialized dialysis equipment. And 00:06:36.110 --> 00:06:38.089 these are not simple machines. No, these are 00:06:38.089 --> 00:06:40.990 complex, expensive medical devices. And you have 00:06:40.990 --> 00:06:43.470 to manage extensive supply chains for dialysate 00:06:43.470 --> 00:06:46.250 and pharmaceuticals. It's a huge logistical challenge. 00:06:46.490 --> 00:06:49.389 That fixed cost base means they need volume and 00:06:49.389 --> 00:06:51.610 they need reliable high margin revenue just to 00:06:51.610 --> 00:06:53.269 cover that massive overhead, which brings us 00:06:53.269 --> 00:06:55.790 to the human scale of it all. They employed 76 00:06:55.790 --> 00:06:59.459 ,000 people in 2024. Which cements their status 00:06:59.459 --> 00:07:02.019 as a major US employer. And it earned them the 00:07:02.019 --> 00:07:05.540 341st spot on the Fortune 500 list. And look, 00:07:05.579 --> 00:07:08.000 when you hit the Fortune 500, you are a critical 00:07:08.000 --> 00:07:10.360 part of the US economy. This leads us directly 00:07:10.360 --> 00:07:12.500 to the major stakeholders, the institutional 00:07:12.500 --> 00:07:14.759 investors who rely on this company's stability 00:07:14.759 --> 00:07:17.339 and predictability. And here's where it gets 00:07:17.339 --> 00:07:19.240 really interesting for anyone following high 00:07:19.240 --> 00:07:22.899 finance. The massive shadow of Berkshire Hathaway. 00:07:23.319 --> 00:07:26.319 Warren Buffett's investment vehicle is listed 00:07:26.319 --> 00:07:28.990 as a major owner. The inclusion of Berkshire 00:07:28.990 --> 00:07:31.410 Hathaway is in many ways the ultimate validation 00:07:31.410 --> 00:07:34.050 of DeVita's business model. Buffett generally 00:07:34.050 --> 00:07:37.110 seeks stable, predictable, long -term, profitable 00:07:37.110 --> 00:07:39.930 businesses. And the non -cyclical, mandatory 00:07:39.930 --> 00:07:43.129 nature of dialysis care fits that criteria perfectly. 00:07:43.410 --> 00:07:45.870 People don't stop needing dialysis in a recession. 00:07:46.230 --> 00:07:48.490 We found a fascinating little discrepancy in 00:07:48.490 --> 00:07:50.050 our source material regarding that ownership 00:07:50.050 --> 00:07:52.370 stake, which is worth discussing because it illustrates 00:07:52.370 --> 00:07:54.509 the complexity of dealing with public corporate 00:07:54.509 --> 00:07:56.850 data. Yeah, that was interesting. Our source 00:07:56.850 --> 00:07:59.079 list. two slightly different figures for Berkshire 00:07:59.079 --> 00:08:02.399 Hathaway's stake, 41 .2 % in the general information 00:08:02.399 --> 00:08:06.300 box, but then 32 % in the detailed list of public 00:08:06.300 --> 00:08:08.620 company ownership positions. And that difference, 00:08:08.639 --> 00:08:10.379 it could stem from several factors. It could 00:08:10.379 --> 00:08:11.980 be a difference in reporting dates. It could 00:08:11.980 --> 00:08:14.579 be whether certain convertible shares are included 00:08:14.579 --> 00:08:16.720 in one figure but not the other, or just how 00:08:16.720 --> 00:08:18.860 different regulatory bodies categorize ownership. 00:08:19.160 --> 00:08:22.110 But the key takeaway for you listening. Is not 00:08:22.110 --> 00:08:24.850 the exact percentage. No, the point is the profound 00:08:24.850 --> 00:08:27.129 significance. I mean, even at the lower figure 00:08:27.129 --> 00:08:30.610 of 32 percent, a single entity, Berkshire Hathaway, 00:08:30.790 --> 00:08:33.629 controls nearly a third of this multibillion 00:08:33.629 --> 00:08:36.029 dollar life sustaining health care provider. 00:08:36.269 --> 00:08:38.769 It's a huge stamp of confidence placed on a company 00:08:38.769 --> 00:08:41.509 whose stability, as we are about to see, hinges 00:08:41.509 --> 00:08:44.789 entirely on its ability to navigate the complex 00:08:44.789 --> 00:08:48.129 and sometimes fraught financial gap between what 00:08:48.129 --> 00:08:50.350 the government pays and what commercial insurers 00:08:50.350 --> 00:08:53.679 pay. And that duality right there defines everything 00:08:53.679 --> 00:08:56.299 DaVita is. If Section 1 was about who DaVita 00:08:56.299 --> 00:08:58.559 is, this section is about how DaVita makes its 00:08:58.559 --> 00:09:01.179 money. And this is the absolute financial core 00:09:01.179 --> 00:09:03.559 of this entire deep dive. If you understand the 00:09:03.559 --> 00:09:05.519 mechanics of the dynamics, you understand the 00:09:05.519 --> 00:09:08.139 company's incentives, its strategies, and its 00:09:08.139 --> 00:09:10.059 history of legal troubles. This is the critical 00:09:10.059 --> 00:09:11.919 insight we really need to drive home for you. 00:09:12.120 --> 00:09:14.620 Kidney dialysis is unlike many other medical 00:09:14.620 --> 00:09:17.480 procedures because of a specific federal rule. 00:09:17.639 --> 00:09:20.429 What's the rule? Medicare covers nearly all individuals 00:09:20.429 --> 00:09:23.009 with end -stage renal disease, regardless of 00:09:23.009 --> 00:09:25.490 their age, typically after a short waiting period. 00:09:25.870 --> 00:09:28.250 This guarantees that most patients requiring 00:09:28.250 --> 00:09:31.309 dialysis will have government coverage. Okay, 00:09:31.350 --> 00:09:33.330 so the government is basically the default payer 00:09:33.330 --> 00:09:35.029 for this condition. Let's put some numbers to 00:09:35.029 --> 00:09:38.919 that. Our sources show for 2023, a staggering 00:09:38.919 --> 00:09:42.960 89 % of DaVita's patients were covered by government 00:09:42.960 --> 00:09:45.919 -based health insurance programs. So that's primarily 00:09:45.919 --> 00:09:48.460 Medicare, but also some Medicaid. Nine out of 00:09:48.460 --> 00:09:50.559 every 10 patients served by DaVita are relying 00:09:50.559 --> 00:09:52.590 on the federal government to pay the bill. That 00:09:52.590 --> 00:09:56.370 89 % represents volume and stability. It's predictable 00:09:56.370 --> 00:09:59.269 revenue. It ensures that the lights stay on and 00:09:59.269 --> 00:10:01.549 the expensive fixed costs we just discussed are 00:10:01.549 --> 00:10:03.730 generally covered. However... There's always 00:10:03.730 --> 00:10:06.250 a however. There is. When we look at the revenue 00:10:06.250 --> 00:10:08.649 contribution breakdown for that same year, the 00:10:08.649 --> 00:10:11.070 picture dramatically flips and it reveals the 00:10:11.070 --> 00:10:13.269 real profit driver. Okay, let's see that flip. 00:10:13.470 --> 00:10:16.590 So, while 89 % of patients were government covered, 00:10:16.730 --> 00:10:19.889 those programs only accounted for 67 % of the 00:10:19.889 --> 00:10:22.379 company's total revenue. Which means the remaining 00:10:22.379 --> 00:10:26.419 11 % of patients, just that small slice covered 00:10:26.419 --> 00:10:29.500 by commercial or private insurance, we're generating 00:10:29.500 --> 00:10:32.740 the remaining 33 % of the company's total revenue. 00:10:33.039 --> 00:10:37.259 Wow. That is a massive disproportion. It's huge. 00:10:37.539 --> 00:10:40.039 So we have a small fraction of the patient population 00:10:40.039 --> 00:10:42.899 generating one -third of the total revenue. But 00:10:42.899 --> 00:10:45.019 here's the most important sentence in this entire 00:10:45.019 --> 00:10:46.779 analysis, and this is according to our source 00:10:46.779 --> 00:10:49.919 material. Those commercial payers. which accounted 00:10:49.919 --> 00:10:52.860 for that remaining 33 % of revenues in 2023, 00:10:53.279 --> 00:10:55.720 generate nearly all of the company's profit. 00:10:55.840 --> 00:10:59.279 That is the engine. The volume, that 89 % government 00:10:59.279 --> 00:11:01.700 segment, it covers the overhead and provides 00:11:01.700 --> 00:11:04.919 the scale necessary for efficiency. But the profit, 00:11:05.039 --> 00:11:07.639 the money that funds acquisitions, stock buybacks 00:11:07.639 --> 00:11:09.480 and shareholder returns, which includes that 00:11:09.480 --> 00:11:12.279 enormous Berkshire Hathaway stake, comes almost 00:11:12.279 --> 00:11:14.620 entirely from that high margin commercial side. 00:11:14.799 --> 00:11:16.740 We absolutely need to spend time on the why. 00:11:16.879 --> 00:11:19.379 Why are commercial payers reimbursing DaVita 00:11:19.379 --> 00:11:21.960 at such an astronomical disproportionate rate 00:11:21.960 --> 00:11:24.529 compared to Medicare? The why comes down to a 00:11:24.529 --> 00:11:27.009 simple concept fixed rates versus negotiation 00:11:27.009 --> 00:11:29.750 leverage. Government payments from Medicare and 00:11:29.750 --> 00:11:33.169 Medicaid are set through fixed, often bundled 00:11:33.169 --> 00:11:34.990 rates determined by the Centers for Medicare 00:11:34.990 --> 00:11:38.690 and Medicaid Services or CMS. These rates are 00:11:38.690 --> 00:11:41.250 intentionally set low to control federal spending 00:11:41.250 --> 00:11:44.480 and Vita has to accept them. Because of that 00:11:44.480 --> 00:11:46.860 mandatory Medicare coverage rule. They have no 00:11:46.860 --> 00:11:49.740 choice. Right. They are, on the government side, 00:11:50.059 --> 00:11:52.960 a price taker. A price taker. Precisely. But 00:11:52.960 --> 00:11:56.120 on the commercial side, DaVita is a price maker. 00:11:56.360 --> 00:11:59.409 How so? Commercial payers reimburse DaVita at 00:11:59.409 --> 00:12:01.649 a much higher rate because, remember, DaVita 00:12:01.649 --> 00:12:03.970 and Fresenius control the market. It's that duopoly 00:12:03.970 --> 00:12:06.769 we talked about. Since dialysis care is mandatory, 00:12:07.149 --> 00:12:09.590 an insurer can't just tell its members, oh, sorry, 00:12:09.710 --> 00:12:11.789 we won't cover treatment at the nearest DaVita 00:12:11.789 --> 00:12:13.429 center. They have a riot on their hands. They 00:12:13.429 --> 00:12:16.149 would. They must include the provider in their 00:12:16.149 --> 00:12:18.669 network. And DaVita uses its massive footprint 00:12:18.669 --> 00:12:22.289 to negotiate extremely high rates, sometimes 00:12:22.289 --> 00:12:24.450 hundreds of percent higher than the Medicare 00:12:24.450 --> 00:12:27.350 rate for the exact same service in the exact 00:12:27.350 --> 00:12:29.990 same chair with the exact same technician. So 00:12:29.990 --> 00:12:31.710 this high commercial rate isn't just padding. 00:12:31.809 --> 00:12:34.870 It's structural to their entire business. If 00:12:34.870 --> 00:12:36.990 DaVita lost its high -margin commercial business, 00:12:37.269 --> 00:12:39.110 the company would likely cease to be profitable, 00:12:39.330 --> 00:12:41.389 regardless of the steady stream of government 00:12:41.389 --> 00:12:43.710 patience. Absolutely. It creates an existential 00:12:43.710 --> 00:12:46.330 imperative for the company to attract and retain 00:12:46.330 --> 00:12:49.470 commercially insured patients. It explains every 00:12:49.470 --> 00:12:52.590 strategic move we're about to discuss. It explains 00:12:52.590 --> 00:12:55.649 the imperative for ruthless efficiency to squeeze 00:12:55.649 --> 00:12:58.909 every penny out of the government side. And crucially, 00:12:59.029 --> 00:13:02.399 it explains the legal history. As you'll see, 00:13:02.519 --> 00:13:05.220 any alleged fraud or kickback scheme can often 00:13:05.220 --> 00:13:07.480 be traced back to the drive to capture, retain 00:13:07.480 --> 00:13:10.100 or maximize payments from that highly valuable, 00:13:10.299 --> 00:13:13.639 high margin commercial slice of the pie. So the 00:13:13.639 --> 00:13:16.899 goal is volume, yes. But the profit driver is 00:13:16.899 --> 00:13:19.600 optimizing the payer mix, getting those commercially 00:13:19.600 --> 00:13:22.240 insured patients onto the dialysis chairs at 00:13:22.240 --> 00:13:24.799 the Vita centers. That insight is essential to 00:13:24.799 --> 00:13:27.120 carry forward. It's the key to the whole story. 00:13:27.320 --> 00:13:29.559 And that financial structure didn't just appear 00:13:29.559 --> 00:13:32.879 overnight. It's the result of decades of massive 00:13:32.879 --> 00:13:35.620 corporate pivots, high -risk financial engineering, 00:13:35.820 --> 00:13:39.799 and near -catastrophic failures. Let's trace 00:13:39.799 --> 00:13:44.100 how this US $12 .8 billion entity got here, starting 00:13:44.100 --> 00:13:46.230 with its inception. The company was established 00:13:46.230 --> 00:13:49.309 relatively far back in 1979. Initially, it was 00:13:49.309 --> 00:13:52.830 called Medical Ambulatory Care, Inc. And crucially, 00:13:52.950 --> 00:13:55.250 it was born as a subsidiary of a much larger 00:13:55.250 --> 00:13:57.710 parent company, National Medical Enterprises, 00:13:57.769 --> 00:13:59.769 Inc. Which later evolved into Tenet Healthcare, 00:13:59.950 --> 00:14:01.669 as you mentioned earlier. Right. So this gave 00:14:01.669 --> 00:14:03.789 it established resources and roots from day one. 00:14:03.809 --> 00:14:05.629 It wasn't just a startup. But the first major 00:14:05.629 --> 00:14:09.070 financial shockwave came in 1994. And it wasn't 00:14:09.070 --> 00:14:11.330 through organic growth, but through high stakes 00:14:11.330 --> 00:14:14.309 financial maneuvering. The Leverage Buyout, or 00:14:14.309 --> 00:14:17.330 LBO. In August 1994, 70 % of the company was 00:14:17.330 --> 00:14:20.230 acquired by DLJ Merchant Banking Partners. An 00:14:20.230 --> 00:14:22.870 LBO is essentially buying a company primarily 00:14:22.870 --> 00:14:25.350 using debt, expecting the company's future cash 00:14:25.350 --> 00:14:27.870 flow to pay off that debt. It's a high -risk, 00:14:27.990 --> 00:14:29.870 high -reward move. And the total value of the 00:14:29.870 --> 00:14:34.029 deal was $75 .5 million. But what was DLJ's actual 00:14:34.029 --> 00:14:36.850 skin in the game? That's the amazing part. Their 00:14:36.850 --> 00:14:39.230 initial equity investment was surprisingly small. 00:14:39.850 --> 00:14:43.269 just $10 .5 million. They were betting big on 00:14:43.269 --> 00:14:45.710 the company's future using mostly borrowed money. 00:14:46.129 --> 00:14:48.990 And following the LBO, they renamed it Total 00:14:48.990 --> 00:14:51.470 Renal Care Holdings, Inc. The clock immediately 00:14:51.470 --> 00:14:53.629 started ticking for the investors. I mean, LBO 00:14:53.629 --> 00:14:56.009 firms typically look for a quick exit to monetize 00:14:56.009 --> 00:14:58.070 their investment, and Total Renal Care wasted 00:14:58.070 --> 00:15:00.210 no time. Exactly. They turned it into a public 00:15:00.210 --> 00:15:03.360 company just over a year later. The initial public 00:15:03.360 --> 00:15:07.120 offering, the IPO, happened in October 1995 and 00:15:07.120 --> 00:15:11.179 successfully raised $107 million. This infusion 00:15:11.179 --> 00:15:13.299 of cash allowed the company to pay down some 00:15:13.299 --> 00:15:15.899 of that LBO debt and provided the investors their 00:15:15.899 --> 00:15:18.399 first real opportunity to cash out. And the investor 00:15:18.399 --> 00:15:21.779 payoff for DLJ was just spectacular. By December 00:15:21.779 --> 00:15:24.779 1996, our sources show that DLJ had made a stunning 00:15:24.779 --> 00:15:29.000 386 % return on its initial $10 .5 million investment. 00:15:29.320 --> 00:15:30.620 Just think about what that means. You're turning 00:15:30.620 --> 00:15:34.139 $10 .5 million into over $40 million in just 00:15:34.139 --> 00:15:36.960 two years. That level of rapid, high -margin 00:15:36.960 --> 00:15:38.960 financial success in the healthcare space sets 00:15:38.960 --> 00:15:40.919 an extremely aggressive precedent for future 00:15:40.919 --> 00:15:43.259 leadership. It builds an expectation. It creates 00:15:43.259 --> 00:15:45.519 a culture of expectation for exponential growth, 00:15:45.659 --> 00:15:48.440 and often that expectation drives leaders to 00:15:48.440 --> 00:15:50.480 make really aggressive moves that can lead to 00:15:50.480 --> 00:15:53.000 instability, which is precisely what happened 00:15:53.000 --> 00:15:55.820 in the late 1990s. They ran straight into a massive 00:15:55.820 --> 00:15:58.120 corporate crisis following an acquisition headache. 00:15:58.299 --> 00:16:01.519 In February 1998, they acquired a major rival, 00:16:01.779 --> 00:16:05.179 Renal Treatment Centers, for $1 .3 billion in 00:16:05.179 --> 00:16:07.440 stock. This was supposed to be a market -defining 00:16:07.440 --> 00:16:10.379 merger, the big move to consolidate power. Instead, 00:16:10.480 --> 00:16:12.460 it turned into what you could call corporate 00:16:12.460 --> 00:16:15.379 indigestion. The sources are very clear. The 00:16:15.379 --> 00:16:17.480 integration of this massive acquisition went 00:16:17.480 --> 00:16:20.759 poorly. And look, combining two large, geographically 00:16:20.759 --> 00:16:23.139 dispersed health care providers is always difficult. 00:16:23.340 --> 00:16:25.919 You're trying to harmonize IT systems, clinical 00:16:25.919 --> 00:16:29.000 protocols, corporate cultures. It's a nightmare. 00:16:29.220 --> 00:16:31.360 And this failure led directly to chaos at the 00:16:31.360 --> 00:16:33.679 top, resulting in the simultaneous resignation 00:16:33.679 --> 00:16:37.279 of the CEO and the CFO in July 1999. That's a 00:16:37.279 --> 00:16:39.460 huge red flag for the market. The market reacted 00:16:39.460 --> 00:16:41.899 immediately and harshly. The stock, which had 00:16:41.899 --> 00:16:44.659 tripled in value between the 1995 IPO and 1998, 00:16:45.000 --> 00:16:47.860 just collapsed. By July 1999, it had dropped 00:16:47.860 --> 00:16:50.980 71 % year to date. This was a near -death experience, 00:16:51.259 --> 00:16:53.639 a full -blown financial crisis for the organization 00:16:53.639 --> 00:16:56.559 then known as Total Renal Care. They were on 00:16:56.559 --> 00:16:59.360 the brink. So to stabilize the failing company, 00:16:59.539 --> 00:17:02.639 the board brought in new leadership. Ken Cheturi, 00:17:02.840 --> 00:17:05.759 who was 43 at the time, was named CEO in October 00:17:05.759 --> 00:17:09.220 1999. His initial task wasn't growth. It was 00:17:09.220 --> 00:17:12.500 survival and radical internal overhaul. He had 00:17:12.500 --> 00:17:14.559 to stop the bleeding. This turnaround effort 00:17:14.559 --> 00:17:16.640 culminated in the company's symbolic rebirth. 00:17:17.289 --> 00:17:19.930 In 2000, they shed the ballast of the failing 00:17:19.930 --> 00:17:22.349 acquisition integration, they sold off their 00:17:22.349 --> 00:17:24.990 non -U .S. operations to Focus, and they renamed 00:17:24.990 --> 00:17:27.569 the company DaVita Inc. And the rebranding itself 00:17:27.569 --> 00:17:30.970 was strategic and, frankly, brilliant. The name 00:17:30.970 --> 00:17:33.490 DaVita is derived from the Italian phrase der 00:17:33.490 --> 00:17:36.640 vita, which means to give life. It was a very 00:17:36.640 --> 00:17:38.819 conscious effort to move past the financial failures 00:17:38.819 --> 00:17:40.900 and the stock collapse associated with the total 00:17:40.900 --> 00:17:43.759 renal care name and recenter the company's identity 00:17:43.759 --> 00:17:45.920 around its noble, life -sustaining mission. A 00:17:45.920 --> 00:17:48.680 fresh start. Following that stabilization, the 00:17:48.680 --> 00:17:51.440 next decade saw a return to that aggressive growth 00:17:51.440 --> 00:17:54.180 by acquisition strategy. The focus was on market 00:17:54.180 --> 00:17:56.220 share dominance, which made them the giant they 00:17:56.220 --> 00:17:58.940 are today. The first major post -rebirth acquisition 00:17:58.940 --> 00:18:03.079 was Gambro Healthcare in October 2005. That was 00:18:03.079 --> 00:18:05.259 a crucial move to solidify their U .S. market 00:18:05.259 --> 00:18:08.180 position against Phrygianus, but they weren't 00:18:08.180 --> 00:18:10.500 done trying to expand their scope. Then came 00:18:10.500 --> 00:18:12.500 what we termed the medical group experiment. 00:18:13.099 --> 00:18:15.980 In 2012, DaVita acquired healthcare partners 00:18:15.980 --> 00:18:21.880 for a massive $4 .42 billion. They later rebranded 00:18:21.880 --> 00:18:24.019 this entire division as DaVita Medical Group 00:18:24.019 --> 00:18:27.589 in 2016, and the strategic goal was clear. By 00:18:27.589 --> 00:18:29.829 owning primary care, specialty care, and urgent 00:18:29.829 --> 00:18:32.150 care groups, they could potentially control the 00:18:32.150 --> 00:18:34.950 referral streams of ESRD patients directly to 00:18:34.950 --> 00:18:37.089 their high -margin dialysis centers. It was an 00:18:37.089 --> 00:18:39.089 attempt at vertical integration, controlling 00:18:39.089 --> 00:18:41.109 the patient journey from the moment of diagnosis 00:18:41.109 --> 00:18:43.450 all the way to treatment. But managing massive 00:18:43.450 --> 00:18:45.890 decentralized physician practices is a whole 00:18:45.890 --> 00:18:48.269 different ballgame from running efficient standardized 00:18:48.269 --> 00:18:51.349 dialysis centers. And the experiment, well, it 00:18:51.349 --> 00:18:53.589 didn't last. By 2019, they performed a major 00:18:53.589 --> 00:18:56.240 strategic pivot. selling the entire DaVita Medical 00:18:56.240 --> 00:18:58.319 Group division to UnitedHealth Group's Optum 00:18:58.319 --> 00:19:01.880 division for $4 .3 billion. And what's so fascinating 00:19:01.880 --> 00:19:04.619 here is the financial outcome. They walked away 00:19:04.619 --> 00:19:07.039 from this multi -billion dollar strategic pivot 00:19:07.039 --> 00:19:09.720 and they essentially recouped the entire initial 00:19:09.720 --> 00:19:11.519 investment. They basically got their money back. 00:19:11.740 --> 00:19:14.339 They did. It demonstrates incredible financial 00:19:14.339 --> 00:19:17.440 savvy in their exit strategy. They realized the 00:19:17.440 --> 00:19:20.180 core business was dialysis. They jettisoned the 00:19:20.180 --> 00:19:22.819 distraction without a significant loss and they 00:19:22.819 --> 00:19:25.180 immediately refocused resources on their core 00:19:25.180 --> 00:19:28.500 profit drivers. And that focus led to a steady 00:19:28.500 --> 00:19:31.279 stream of smaller, more strategic acquisitions 00:19:31.279 --> 00:19:34.039 that demonstrated a consistent... expansion strategy 00:19:34.039 --> 00:19:36.680 in specific high growth or high value regions. 00:19:36.900 --> 00:19:39.240 We see clear examples of this focus regional 00:19:39.240 --> 00:19:42.539 strategy. In 2014, they acquired Colorado Springs 00:19:42.539 --> 00:19:45.519 Health Partners, integrating 600 employees and 00:19:45.519 --> 00:19:48.279 110 ,000 patients into their ecosystem. And then 00:19:48.279 --> 00:19:50.839 in 2016. In 2016, they picked up the Everett 00:19:50.839 --> 00:19:52.900 Clinic Medical Group, a huge practice in the 00:19:52.900 --> 00:19:56.460 Seattle area, with 20 sites and 315 ,000 patients 00:19:56.460 --> 00:20:00.079 for $385 million. And then again in 2017, they 00:20:00.079 --> 00:20:02.599 acquired Well Health Quality Care. So these regional 00:20:02.599 --> 00:20:05.220 expansions, they highlight a strategy of buying 00:20:05.220 --> 00:20:08.319 up the local competition and, more importantly, 00:20:08.539 --> 00:20:12.019 key referral sources. It's this decades -long 00:20:12.019 --> 00:20:14.900 persistent drive for market consolidation that 00:20:14.900 --> 00:20:17.559 leads us directly to the enormous price the company 00:20:17.559 --> 00:20:19.460 has paid in legal settlements and regulatory 00:20:19.460 --> 00:20:22.940 actions. The growth had consequences. If section 00:20:22.940 --> 00:20:25.720 two explained the motive, that relentless chase 00:20:25.720 --> 00:20:27.859 for the high margin commercial patient, this 00:20:27.859 --> 00:20:31.000 section illustrates the consequences. The history 00:20:31.000 --> 00:20:33.299 of DaVita is marked by a clear and expensive 00:20:33.299 --> 00:20:35.680 pattern of settling very serious allegations 00:20:35.680 --> 00:20:38.339 of fraud and misconduct, underscoring the high 00:20:38.339 --> 00:20:40.359 stakes environment of subsidized health care. 00:20:40.460 --> 00:20:42.420 Let's start with one of the biggest initial hits. 00:20:42.960 --> 00:20:46.000 The illegal kickbacks case in 2014. DaVita agreed 00:20:46.000 --> 00:20:49.220 to pay a massive $350 million settlement. So 00:20:49.220 --> 00:20:51.240 to connect this back to the core business model 00:20:51.240 --> 00:20:53.660 we talked about, why would a dialysis provider 00:20:53.660 --> 00:20:56.059 pay kickbacks? For the patients. For the right 00:20:56.059 --> 00:20:58.640 patients. Because the commercially insured patients 00:20:58.640 --> 00:21:01.460 are the ones who generate all the profit. The 00:21:01.460 --> 00:21:03.779 allegation was that DaVita provided illegal financial 00:21:03.779 --> 00:21:06.539 incentives to doctors to ensure those highly 00:21:06.539 --> 00:21:09.400 valuable patient referrals were directed specifically 00:21:09.400 --> 00:21:12.039 to DaVita's centers, keeping them out of the 00:21:12.039 --> 00:21:15.200 hands of competitors. So a $350 million penalty 00:21:15.200 --> 00:21:18.039 is really just the cost of doing business when 00:21:18.039 --> 00:21:20.039 you are aggressively protecting that critical 00:21:20.039 --> 00:21:23.079 11 % of your payer mix. You could certainly see 00:21:23.079 --> 00:21:26.319 it that way. The very next year, 2015, brought 00:21:26.319 --> 00:21:28.799 an even larger settlement concerning drug waste 00:21:28.799 --> 00:21:32.019 and billing fraud. DaVita agreed to pay $450 00:21:32.019 --> 00:21:34.950 million for this one. This case highlighted systemic 00:21:34.950 --> 00:21:37.150 fraud aimed specifically at the government system, 00:21:37.430 --> 00:21:39.769 at Medicare. The allegation involved seeking 00:21:39.769 --> 00:21:41.589 reimbursement from the U .S. federal government 00:21:41.589 --> 00:21:44.269 for drugs that were unnecessarily disposed of. 00:21:44.450 --> 00:21:46.569 How does that work? Well, many drugs used in 00:21:46.569 --> 00:21:49.490 dialysis, like those for anemia, come in multidose 00:21:49.490 --> 00:21:52.289 vials. So if a doctor uses only a fraction of 00:21:52.289 --> 00:21:54.650 the drug from a vial on one patient, the remaining 00:21:54.650 --> 00:21:57.289 drug often has to be discarded for safety reasons. 00:21:57.630 --> 00:21:59.950 DeVito was accused of billing Medicare for the 00:21:59.950 --> 00:22:02.970 entire vial multiple times. So they'd use a little 00:22:03.019 --> 00:22:04.720 on one patient, bill for the whole thing, use 00:22:04.720 --> 00:22:06.420 a little more on another patient, bill for the 00:22:06.420 --> 00:22:08.779 whole thing again. They were maximizing payment 00:22:08.779 --> 00:22:12.039 by essentially turning necessary waste into a 00:22:12.039 --> 00:22:16.240 systematic revenue stream. A $450 million settlement 00:22:16.240 --> 00:22:18.839 indicates this practice was probably widespread 00:22:18.839 --> 00:22:21.720 and longstanding. Here's where the focus shifts 00:22:21.720 --> 00:22:24.619 from financial fraud to patient safety, bringing 00:22:24.619 --> 00:22:28.069 the human stakes back into sharp focus. In 2018, 00:22:28.509 --> 00:22:31.049 DaVita faced devastating wrongful death claims, 00:22:31.190 --> 00:22:34.910 and this resulted in a jury awarding $383 million 00:22:34.910 --> 00:22:37.710 to the families of three patients. This case 00:22:37.710 --> 00:22:39.950 centered on the ultimate failure of care quality. 00:22:40.210 --> 00:22:42.710 The patients tragically died from cardiac arrest 00:22:42.710 --> 00:22:44.490 after receiving treatment at DaVita centers. 00:22:44.730 --> 00:22:47.250 And while the legal specifics are complex, the 00:22:47.250 --> 00:22:48.930 verdict suggests that cost -cutting measures 00:22:48.930 --> 00:22:51.609 or operational lapses. Driven by that intense 00:22:51.609 --> 00:22:54.190 need for efficiency we talked about. Exactly. 00:22:54.450 --> 00:22:57.170 Driven by the need to make the low margin government 00:22:57.170 --> 00:23:00.789 segment work. May have had catastrophic consequences 00:23:00.789 --> 00:23:04.170 for patient safety. This massive award is a stark 00:23:04.170 --> 00:23:06.970 reminder that in health care, efficiency cannot 00:23:06.970 --> 00:23:09.849 come at the expense of quality. Also in 2018, 00:23:09.990 --> 00:23:12.450 we saw another major False Claims Act violation. 00:23:12.509 --> 00:23:14.910 This one focused on inflated payments settled 00:23:14.910 --> 00:23:18.789 for $270 million. And this one touches on a specific 00:23:18.789 --> 00:23:21.970 mechanism of fraud related to Medicare Advantage 00:23:21.970 --> 00:23:25.009 plans. This is a complex but really crucial area 00:23:25.009 --> 00:23:27.690 known as risk adjustment coding or upcoding. 00:23:27.869 --> 00:23:30.549 Explain that. So Medicare Advantage plans are 00:23:30.549 --> 00:23:33.029 run by private insurers, but they're funded by 00:23:33.029 --> 00:23:35.549 the government. And they receive higher federal 00:23:35.549 --> 00:23:37.970 payments for patients who are deemed sicker or 00:23:37.970 --> 00:23:40.289 more complex, those with higher risk scores. 00:23:40.710 --> 00:23:43.230 The allegation was that DaVita provided inaccurate 00:23:43.230 --> 00:23:46.109 information, essentially exaggerating the severity 00:23:46.109 --> 00:23:48.170 or complexity of patients' conditions. Which 00:23:48.170 --> 00:23:50.089 made the patients look sicker on paper than they 00:23:50.089 --> 00:23:52.329 were. Right. And this caused the Medicare Advantage 00:23:52.329 --> 00:23:54.450 plans to receive inflated payments from the government, 00:23:54.690 --> 00:23:56.670 which in turn allowed DeVita to charge those 00:23:56.670 --> 00:23:59.269 plans higher rates. It's a roundabout way to 00:23:59.269 --> 00:24:02.269 get more money from this system. The $270 million 00:24:02.269 --> 00:24:04.849 settlement proves the government views these 00:24:04.849 --> 00:24:08.049 inflated coding practices as a clear violation 00:24:08.049 --> 00:24:11.029 of the False Claims Act. And there's a specific 00:24:11.029 --> 00:24:13.549 fascinating detail here that illustrates the 00:24:13.549 --> 00:24:16.349 power of federal law. The whistleblower. Exactly. 00:24:16.609 --> 00:24:19.130 The whistleblower, a man named James Swobin, 00:24:19.170 --> 00:24:21.549 who brought the initial action, received a bounty 00:24:21.549 --> 00:24:24.589 of $10 million for exposing the scheme. That 00:24:24.589 --> 00:24:27.109 payout shows the scale and value of the information 00:24:27.109 --> 00:24:29.829 he provided to the government. It's a huge incentive 00:24:29.829 --> 00:24:32.390 for insiders to come forward. Moving into the 00:24:32.390 --> 00:24:35.309 2020s, the legal scrutiny shifted a bit, from 00:24:35.309 --> 00:24:38.170 billing Medicare to labor market practices and 00:24:38.170 --> 00:24:40.910 antitrust concerns, reflecting DeVita's increasing 00:24:40.910 --> 00:24:44.630 market power. In July 2021, a federal grand jury 00:24:44.630 --> 00:24:47.809 indicted DeVita and former CEO Kent Thury. The 00:24:47.809 --> 00:24:50.269 same CEO who had led the company's rebirth after 00:24:50.269 --> 00:24:52.349 the crisis. It's the very same one. They were 00:24:52.349 --> 00:24:54.490 indicted on charges of labor market collusion. 00:24:54.589 --> 00:24:56.589 What was the allegation there? The allegation 00:24:56.589 --> 00:24:58.829 was that DaVita engaged in no poach agreements. 00:24:58.950 --> 00:25:01.609 So conspiracies with a competitor, surgical care 00:25:01.609 --> 00:25:04.130 affiliates to suppress competition for the services 00:25:04.130 --> 00:25:06.809 of certain senior level employees. So they agreed 00:25:06.809 --> 00:25:08.869 not to hire each other's executives. Essentially, 00:25:08.970 --> 00:25:12.250 yes. And these kinds of conspiracies stifle wage 00:25:12.250 --> 00:25:14.990 growth and employee mobility. While it's not 00:25:14.990 --> 00:25:17.789 related to patient fraud, it shows regulatory 00:25:17.789 --> 00:25:20.289 bodies are scrutinizing every lever DeVita pulls 00:25:20.289 --> 00:25:22.750 to maintain profitability and control costs, 00:25:22.990 --> 00:25:26.329 including those related to its 76 ,000 employees. 00:25:26.710 --> 00:25:28.930 There's a major win for the company here, though. 00:25:29.519 --> 00:25:31.539 This one didn't end in a settlement. That's right. 00:25:31.960 --> 00:25:34.400 Despite the federal indictment, both the company 00:25:34.400 --> 00:25:36.980 and Thurry were acquitted by a jury in April 00:25:36.980 --> 00:25:40.140 2022. This really demonstrates the challenge 00:25:40.140 --> 00:25:42.579 the government faces improving these complex, 00:25:43.019 --> 00:25:45.839 white -collar, anti -collusion cases beyond a 00:25:45.839 --> 00:25:47.900 reasonable doubt, even with extensive evidence. 00:25:48.240 --> 00:25:49.940 But the regulatory pressure from the Federal 00:25:49.940 --> 00:25:52.759 Trade Commission, the FTC, it didn't let up. 00:25:52.880 --> 00:25:55.319 They focused squarely on DeVita's long -term 00:25:55.319 --> 00:25:57.519 strategy of aggressive regional consolidation. 00:25:57.640 --> 00:26:01.180 Right. In 2021, the FTC imposed strict limits 00:26:01.180 --> 00:26:03.839 on the company engaging in future mergers, specifically 00:26:03.839 --> 00:26:06.480 in the state of Utah. Why Utah? This was a direct 00:26:06.480 --> 00:26:09.099 regulatory response to the strategy we saw laid 00:26:09.099 --> 00:26:11.400 out in Section 3, buying up local and regional 00:26:11.400 --> 00:26:14.579 competitors. The FTC determined that DaVita had 00:26:14.579 --> 00:26:16.839 become too dominant in the Utah markets through 00:26:16.839 --> 00:26:19.240 these acquisitions, effectively stifling competition 00:26:19.240 --> 00:26:22.650 and giving them undue pricing power. The FTC 00:26:22.650 --> 00:26:25.289 is now actively regulating DaVita's ability to 00:26:25.289 --> 00:26:27.589 grow through acquisitions in regions where its 00:26:27.589 --> 00:26:30.150 market share is already just too high. And this 00:26:30.150 --> 00:26:32.890 leads us to the present moment, marked by a massive 00:26:32.890 --> 00:26:35.529 intensification of scrutiny focused on the duopoly 00:26:35.529 --> 00:26:38.890 structure itself. In 2024, the FTC began investigating 00:26:38.890 --> 00:26:41.549 DaVita, along with its rival, Fresenius Medical 00:26:41.549 --> 00:26:44.390 Care. The allegation is that the two companies 00:26:44.390 --> 00:26:47.230 are using illegal tactics to push smaller dialysis 00:26:47.230 --> 00:26:50.180 companies out of the market. This probe is critical 00:26:50.180 --> 00:26:52.339 because it challenges the very structural foundation 00:26:52.339 --> 00:26:54.920 of the U .S. dialysis industry. And finally, 00:26:55.000 --> 00:26:57.420 the most recent development from May 2025 ties 00:26:57.420 --> 00:27:00.079 all of this legal history, the collusion, the 00:27:00.079 --> 00:27:02.740 duopoly, and the profit imperative into a single 00:27:02.740 --> 00:27:05.960 massive proposed class action lawsuit. This lawsuit 00:27:05.960 --> 00:27:08.140 was filed by the Benefits Fund of the United 00:27:08.140 --> 00:27:12.180 Food and Commercial Workers Local 1776, and it 00:27:12.180 --> 00:27:15.859 targets both DeVita and Fresenius. The core allegation 00:27:15.859 --> 00:27:18.619 is simple. The two dominant companies illegally 00:27:18.619 --> 00:27:21.539 conspired to inflate treatment costs for dialysis 00:27:21.539 --> 00:27:24.440 patients by billions of dollars. So if that allegation 00:27:24.440 --> 00:27:27.019 is proven, it confirms the direct link we established 00:27:27.019 --> 00:27:29.799 back in Section 2. It does. That small percentage 00:27:29.799 --> 00:27:32.059 of commercial revenue is critical for profit. 00:27:32.500 --> 00:27:34.980 If the two market leaders colluded to keep those 00:27:34.980 --> 00:27:37.000 commercial reimbursement rates artificially high, 00:27:37.369 --> 00:27:39.630 then the multi -billion dollar cost of that high 00:27:39.630 --> 00:27:42.490 margin profit slice is ultimately borne by private 00:27:42.490 --> 00:27:45.890 payers, by benefits funds, and indirectly by 00:27:45.890 --> 00:27:47.569 the employers and union members who fund them. 00:27:47.740 --> 00:27:49.859 When you total up just the key settlements and 00:27:49.859 --> 00:27:53.039 verdicts we've covered, $350 million, $450 million, 00:27:53.339 --> 00:27:57.160 $383 million, $283 million, you are looking at 00:27:57.160 --> 00:28:00.299 well over $1 .4 billion paid out in recent years 00:28:00.299 --> 00:28:02.680 alone. Over a billion dollars. That figure, combined 00:28:02.680 --> 00:28:05.240 with the ongoing antitrust scrutiny, paints a 00:28:05.240 --> 00:28:07.559 clear picture of a company whose necessary life 00:28:07.559 --> 00:28:09.799 -saving service is constantly intertwined with 00:28:09.799 --> 00:28:11.980 major financial and legal risk. So what does 00:28:11.980 --> 00:28:14.349 this all mean? Our deep dive into DaVita Inc. 00:28:14.529 --> 00:28:17.650 has truly synthesized the critical tension at 00:28:17.650 --> 00:28:19.450 the heart of essential American health care. 00:28:19.529 --> 00:28:22.049 It really has. On one side, you have a massive, 00:28:22.109 --> 00:28:25.269 highly efficient S &P 500 company providing a 00:28:25.269 --> 00:28:27.829 non -negotiable, life -sustaining medical treatment 00:28:27.829 --> 00:28:32.269 kidney dialysis to over 200 ,000 people. This 00:28:32.269 --> 00:28:35.269 is indispensable service delivery. You can't 00:28:35.269 --> 00:28:38.000 argue with that. It's necessary. But on the other 00:28:38.000 --> 00:28:40.400 side, you have a financial model reliant on leveraging 00:28:40.400 --> 00:28:43.019 the vast disparity between low fixed government 00:28:43.019 --> 00:28:46.119 payments and astronomically high negotiated commercial 00:28:46.119 --> 00:28:48.720 payments. And that pursuit of disproportionate 00:28:48.720 --> 00:28:51.619 profit has repeatedly fueled aggressive strategals, 00:28:51.740 --> 00:28:53.579 resulting in billions in settlements for issues 00:28:53.579 --> 00:28:55.980 ranging from illegal kickbacks and inflated billing 00:28:55.980 --> 00:28:59.000 to devastating wrongful death claims. The history 00:28:59.000 --> 00:29:01.539 we traced, the LBO, the collapse, the rebirth 00:29:01.539 --> 00:29:04.059 as DeVita, the massive acquisitions and the successful 00:29:04.059 --> 00:29:06.920 divestitures. It all shows a corporate entity 00:29:06.920 --> 00:29:09.960 that is relentlessly optimizing itself to extract 00:29:09.960 --> 00:29:12.460 maximum value from a fixed -demand, subsidized 00:29:12.460 --> 00:29:15.430 market. Exactly. And this brings us back to the 00:29:15.430 --> 00:29:18.630 present, focusing on that 2025 class action lawsuit 00:29:18.630 --> 00:29:22.289 and the ongoing FTC probe into the duopoly shared 00:29:22.289 --> 00:29:25.289 with Fresenius. These actions directly target 00:29:25.289 --> 00:29:28.009 the alleged conspiracy to inflate those high 00:29:28.009 --> 00:29:30.529 margin commercial rates. This raises an important 00:29:30.529 --> 00:29:32.829 question for you, the person listening, trying 00:29:32.829 --> 00:29:35.750 to be well informed. When two dominant companies 00:29:35.750 --> 00:29:39.009 with DaVita alone holding 37 percent of the U 00:29:39.009 --> 00:29:41.630 .S. market are repeatedly accused of financial 00:29:41.630 --> 00:29:44.839 misconduct. and are under investigation for allegedly 00:29:44.839 --> 00:29:48.779 conspiring to inflate costs for mandatory life 00:29:48.779 --> 00:29:51.160 -saving care. What does that suggest about the 00:29:51.160 --> 00:29:53.599 true function and future accessibility of critical 00:29:53.599 --> 00:29:55.980 medical services in the United States? When the 00:29:55.980 --> 00:29:58.079 structure of the market ensures that profit comes 00:29:58.079 --> 00:30:00.200 not from serving the majority of patients covered 00:30:00.200 --> 00:30:02.619 by the government but from maximizing the yield 00:30:02.619 --> 00:30:05.069 from the few covered by private money. Well, 00:30:05.089 --> 00:30:07.430 that tension creates a perpetual regulatory environment. 00:30:07.630 --> 00:30:09.809 And it forces us to consider whether the concentration 00:30:09.809 --> 00:30:11.950 of essential care in the hands of these hyper 00:30:11.950 --> 00:30:14.329 -profitable corporate entities can ever be fully 00:30:14.329 --> 00:30:16.309 divorced from financial strategies that push 00:30:16.309 --> 00:30:18.789 the legal and ethical boundaries. It's a complex 00:30:18.789 --> 00:30:21.230 and high -stakes system. And understanding the 00:30:21.230 --> 00:30:23.369 financial dynamics is really the key to understanding 00:30:23.369 --> 00:30:25.970 the headlines. Something for you to mull over 00:30:25.970 --> 00:30:28.349 the next time you hear about health care regulation 00:30:28.349 --> 00:30:31.940 or private insurance premiums. A deep dive into 00:30:31.940 --> 00:30:34.440 the business of giving life. And the cost of 00:30:34.440 --> 00:30:36.259 profit. Thank you for joining us. We'll see you 00:30:36.259 --> 00:30:36.619 next time.